These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21673032)

  • 1. Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice.
    Tsuge M; Takahashi S; Hiraga N; Fujimoto Y; Zhang Y; Mitsui F; Abe H; Kawaoka T; Imamura M; Ochi H; Hayes CN; Chayama K
    J Infect Dis; 2011 Jul; 204(2):224-8. PubMed ID: 21673032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
    Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
    Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes.
    Tabuchi A; Tanaka J; Katayama K; Mizui M; Matsukura H; Yugi H; Shimada T; Miyakawa Y; Yoshizawa H
    J Med Virol; 2008 Dec; 80(12):2064-8. PubMed ID: 19040280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
    Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
    Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.
    Tsuge M; Hiraga N; Akiyama R; Tanaka S; Matsushita M; Mitsui F; Abe H; Kitamura S; Hatakeyama T; Kimura T; Miki D; Mori N; Imamura M; Takahashi S; Hayes CN; Chayama K
    J Gen Virol; 2010 Jul; 91(Pt 7):1854-64. PubMed ID: 20219897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of chimeric mice with livers repopulated by serially subcultured human hepatocytes to hepatitis B virus.
    Utoh R; Tateno C; Yamasaki C; Hiraga N; Kataoka M; Shimada T; Chayama K; Yoshizato K
    Hepatology; 2008 Feb; 47(2):435-46. PubMed ID: 18098326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advance in the study of immunopathobiology of hepatitis B virus infection using HBV transgenic mice].
    Kakimi K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():54-7. PubMed ID: 15453285
    [No Abstract]   [Full Text] [Related]  

  • 8. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
    Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
    Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
    Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
    Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNA.
    Kohno T; Tsuge M; Murakami E; Hiraga N; Abe H; Miki D; Imamura M; Ochi H; Hayes CN; Chayama K
    J Viral Hepat; 2014; 21(9):e89-97. PubMed ID: 24835118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.
    Steenbergen RH; Joyce MA; Lund G; Lewis J; Chen R; Barsby N; Douglas D; Zhu LF; Tyrrell DL; Kneteman NM
    Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G844-54. PubMed ID: 20651006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-species transmission of gibbon and orangutan hepatitis B virus to uPA/SCID mice with human hepatocytes.
    Sa-Nguanmoo P; Tanaka Y; Ratanakorn P; Sugiyama M; Murakami S; Payungporn S; Sommanustweechai A; Mizokami M; Poovorawan Y
    Virus Res; 2011 Jun; 158(1-2):209-15. PubMed ID: 21510984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2012 Dec; 96(3):405-13. PubMed ID: 23072881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune control of hepatitis B virus.
    Bauer T; Sprinzl M; Protzer U
    Dig Dis; 2011; 29(4):423-33. PubMed ID: 21894014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.
    Lütgehetmann M; Bornscheuer T; Volz T; Allweiss L; Bockmann JH; Pollok JM; Lohse AW; Petersen J; Dandri M
    Gastroenterology; 2011 Jun; 140(7):2074-83, 2083.e1-2. PubMed ID: 21376046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.
    Tsuge M; Hiraga N; Takaishi H; Noguchi C; Oga H; Imamura M; Takahashi S; Iwao E; Fujimoto Y; Ochi H; Chayama K; Tateno C; Yoshizato K
    Hepatology; 2005 Nov; 42(5):1046-54. PubMed ID: 16250045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes.
    Verrier ER; Yim SA; Heydmann L; El Saghire H; Bach C; Turon-Lagot V; Mailly L; Durand SC; Lucifora J; Durantel D; Pessaux P; Manel N; Hirsch I; Zeisel MB; Pochet N; Schuster C; Baumert TF
    Hepatology; 2018 Nov; 68(5):1695-1709. PubMed ID: 29679386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
    Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
    J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.